CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

计划入组 81 人 · 首次发布于 2023 年 10 月 26 日

Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell

计划入组 30 人 · 首次发布于 2023 年 3 月 24 日

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

首次发布于 2023 年 7 月 7 日

Anti-EPCAM CAR-T cell therapy (Sinobioway)

Anti-CD5 CAR T-cell therapy

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Shanghai Cell Therapy Research Institute

China

Female Sex Linked to Superior Outcomes in CD19-Directed CAR T-Cell Therapy for Large B-Cell Lymphoma

PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas

Lancet Publishes Phase 1 Data for PeproMene's BAFF-R CAR T: 80% Complete Response, Grade 1-Only Toxicity